Physician profile
James Arthur Simon
NPI 1447259171
$5,952.22
in general payments reported to CMS, 2019-2025
40 companies · $595 in 2025
The $595 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $185 · 2021: $673 · 2022: $1,352 · 2023: $2,422 · 2024: $602 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,434 · Travel and Lodging: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,434.11 |
| Travel and Lodging | $1,185.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,630.16 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $923.74 | 2021-2025 | Lupron Depot, Botox |
| Astellas Pharma US INC | $813.99 | 2019-2023 | Veozah |
| Pfizer INC. | $392.81 | 2019-2025 | |
| Janssen Biotech, INC. | $259.93 | 2021-2024 | Erleada |
| Boston Scientific Corporation | $238.94 | 2020-2023 | Lithovue, Ams 700, Rezum Generator |
| Urovant Sciences INC | $178.47 | 2021-2022 | |
| Coloplast Corp | $177.57 | 2022-2025 | Titan, Speedicath |
| Myriad Genetic Laboratories, INC. | $116.16 | 2021-2024 | Myrisk, Prolaris |
| Sumitomo Pharma America, INC. | $110.45 | 2023-2024 | Gemtesa, Orgovyx |
| Novartis Pharmaceuticals Corporation | $97.90 | 2022-2025 | |
| Conmed Corporation | $79.71 | 2023 | Airseal |
| Allergan, INC. | $78.49 | 2020-2022 | |
| Myovant Sciences INC. | $65.79 | 2022 | |
| Teleflex LLC | $62.69 | 2025 | Barrigel |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.